Skip to content

Associations between sex hormones and lung adenocarcinoma risk in never-smoking women

Associations between sex hormones and lung adenocarcinoma risk in never-smoking women

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101675
Enrollment
Unknown
Registered
2025-04-28
Start date
2024-03-27
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Case group:None
Control group :None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The study population consisted of women in Sichuan, China, who attended West China Hospital from 2024-March to 2025-March 1.Inclusion criteria in case group: A. Pathological diagnosis: Primary lung adenocarcinoma; B. Never-smoking; C. Younger than 75 years old; D. Interview completed within 3 months of initial diagnosis. 2.Inclusion criteria in control group: The women in Sichuan, China, who attended West China Hospital from 2024-March to 2025-March. The frequency matching factors: age (+ / - 5 years), similar attention time, degree of education. A. Never-smoking; B. Younger than 75 years old; Interview completed within 3 months of initial diagnosis; D. Without the diagnosis of carcinoma when including.

Exclusion criteria

Exclusion criteria: 1.Exclusion criteria in case group: Severe econd-hand smoke from the family or workplace: the number of cigarettes in one day from husband smoking is >= 20 and (or) the frequency of second-hand smoking in the workplace is >= 1. 2.Exclusion criteria in control group: Severe econd-hand smoke from the family or workplace: the number of cigarettes in one day from husband smoking is >= 20 and (or) the frequency of second-hand smoking in the workplace is >= 1; The number of the same diagnosis in the control group should be less than 10% of the total number of the included control group.

Design outcomes

Primary

MeasureTime frame
Plasma concentrations of sex hormones;

Countries

China

Contacts

Public ContactQiang Pu

West China Hospital, Sichuan University

puqiang100@163.com+86 189 8060 6738

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026